| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 256, Issue 6 E818-E828, Copyright © 1989 by American Physiological Society
ARTICLES |
E. J. Blanchette-Mackie, H. Masuno, N. K. Dwyer, T. Olivecrona and R. O. Scow
Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
Lipoprotein lipase was immunolocalized by electron microscopy in hearts of young mice; 78% of lipoprotein lipase was in myocytes, 3-6% in extracellular space, and 18% in capillary endothelium. Lipoprotein lipase in myocytes was located primarily in sarcoplasmic reticulum, Golgi sacs, and transport vesicles and also in secretory vesicles at the cell periphery. Lipoprotein lipase in extracellular space was present near the orifice of secretory vesicles of myocytes and in narrow zones spanning the space between myocytes and capillary endothelium. The lowest concentration of lipase associated with endothelial cells was at the basal plasma membrane, whereas the highest concentration was at the surface of luminal projections. Lipoprotein lipase was associated with chylomicrons at the capillary surface but not with chylomicron remnants. Fasting mice for 48 h increased, in heart, lipoprotein lipase activity by 120% and immunolocalized lipase by 270%. The greatest increase (5-fold) occurred at the surface of intraluminal endothelial projections. The findings indicate that lipoprotein lipase in heart is synthesized by myocytes, transferred across extracellular space along cell surfaces and across endothelial cells via vesicles or intracellular channels, and concentrated at the surface of luminal projections of endothelium where the enzyme hydrolyzes triacylglycerol of chylomicrons and very low-density lipoproteins.
This article has been cited by other articles:
|
|
 |
|
  G. Medina-Gomez, R. M. Calvo, and M.-J. Obregon Thermogenic effect of triiodothyroacetic acid at low doses in rat adipose tissue without adverse side effects in the thyroid axis Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E688 - E697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Qi, D. An, G. Kewalramani, Y. Qi, T. Pulinilkunnil, A. Abrahani, U. Al-Atar, S. Ghosh, R. B. Wambolt, M. F. Allard, et al. Altered cardiac fatty acid composition and utilization following dexamethasone-induced insulin resistance Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E420 - E427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. An, G. Kewalramani, D. Qi, T. Pulinilkunnil, S. Ghosh, A. Abrahani, R. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues {beta}-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1120 - E1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pulinilkunnil, D. An, S. Ghosh, D. Qi, G. Kewalramani, G. Yuen, N. Virk, A. Abrahani, and B. Rodrigues Lysophosphatidic acid-mediated augmentation of cardiomyocyte lipoprotein lipase involves actin cytoskeleton reorganization Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2802 - H2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. An, T. Pulinilkunnil, D. Qi, S. Ghosh, A. Abrahani, and B. Rodrigues The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E246 - E253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Merkel, R. H. Eckel, and I. J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation J. Lipid Res., December 1, 2002; 43(12): 1997 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mardy, D. D. Belke, and D. L. Severson Chylomicron metabolism by the isolated perfused mouse heart Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E357 - E364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Nicklas, E. M. Rogus, D. M. Berman, K. E. Dennis, and A. P. Goldberg Responses of adipose tissue lipoprotein lipase to weight loss affect lipid levels and weight regain in women Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1012 - E1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Schultz, E. J. Blanchette-Mackie, and R. O. Scow Adrenal and liver in normal and cld/cld mice synthesize and secrete hepatic lipase, but the lipase is inactive in cld/cld mice J. Lipid Res., February 1, 2000; 41(2): 214 - 225. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Casaroli-Marano, R. García, E. Vilella, G. Olivecrona, M. Reina, and S. Vilaró Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells J. Lipid Res., April 1, 1998; 39(4): 789 - 806. [Abstract] [Full Text]
|
|
|
|
|
|
L. G. Anderson, R. Carroll, H. S. Ewart, A. Acharya, and D. L. Severson Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E759 - E767. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
